Francomano Robert

Chief Commercial Officer at STEMLINE THERAPEUTICS INC

Sold, on record
$72k
Dollars the filings state
Form 4 sales
4
Latest May 4, 2020
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale STEMLINE THERAPEUTICS INCPlan not stated
    Dec 27, 2019 2019

    Sold 2,670 shares at $10.84 ($29k)

    Francomano Robert, Chief Commercial Officer

    Sold 2.6% of holdings ($1.1M position)98,321 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale STEMLINE THERAPEUTICS INCPlan not stated
    Feb 7, 2020 +42 days

    Sold 5,064 shares at $6.72 ($34k)

    Francomano Robert, Chief Commercial Officer

    Sold 5.2% of holdings ($661k position)93,257 shares leftFiling

  3. 3 Form 4 sale STEMLINE THERAPEUTICS INCPlan not stated
    Mar 9, 2020 +31 days

    Sold 1,266 shares at $5.00 ($6k)

    Francomano Robert, Chief Commercial Officer

    Sold 0.6% of holdings ($996k position)197,930 shares leftFiling

  4. 4 Form 4 sale STEMLINE THERAPEUTICS INCPlan not stated
    May 4, 2020 +56 days

    Sold 272 shares at $11.51 ($3k)

    Francomano Robert, Chief Commercial Officer

    Sold 0.1% of holdings ($2.3M position)197,658 shares left0.1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Francomano Robert
Source
May 4, 2020May 6, 2020STEMLINE THERAPEUTICS INCChief Commercial OfficerForm 4 sale272$3k0.1%Plan not statedSEC
Mar 9, 2020Mar 13, 2020STEMLINE THERAPEUTICS INCChief Commercial OfficerForm 4 sale1,266$6k0.6%Plan not statedSEC
Feb 7, 2020Feb 14, 2020STEMLINE THERAPEUTICS INCChief Commercial OfficerForm 4 sale5,064$34k5.2%Plan not statedSEC
Dec 27, 2019Jan 3, 2020STEMLINE THERAPEUTICS INCChief Commercial OfficerForm 4 sale2,670$29k2.6%Plan not statedSEC